XNYS · Healthcare · Drug Manufacturers - Specialty & Generic
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | Q1 2026 | 0.34 | 0.40 | +17.65% | $1.37B | ✅ Beat | +5.48% | -16.73% | — |
| 2026-02-24 | Q4 2025 | 0.11 | 0.13 | +18.18% | $1.14B | ✅ Beat | -0.57% | -5.69% | -6.82% |
| 2025-11-05 |
| Q3 2025 |
| 0.13 |
| 0.19 |
| +46.15% |
| $1.14B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-02-25 | Q4 2024 | 0.15 | 0.14 | -6.67% | $1.02B | ❌ Miss | +4.02% | +0.93% | +1.03% |
| 2024-11-07 | Q3 2024 | 0.12 | 0.13 | +8.33% | $1.03B | ✅ Beat | -2.97% | -3.17% | -11.17% |
| 2024-08-08 | Q2 2024 | 0.24 | 0.30 | +25.00% | $1.02B | ✅ Beat | +0.38% | +12.24% | +13.78% |
| 2024-05-08 | Q1 2024 | 0.27 | 0.34 | +25.93% | $1.21B | ✅ Beat | +1.84% | +0.89% | +7.82% |
| 2024-02-26 | Q4 2023 | 0.11 | 0.08 | -27.27% | $1.03B | ❌ Miss | — | — | — |
Showing last 8 quarters.